As of 2024-09-09, the Relative Valuation of Mesa Laboratories Inc (MLAB) is (1,652.92) USD. This relative valuation is based on P/E multiples. With the latest stock price at 117.96 USD, the upside of Mesa Laboratories Inc based on Relative Valuation is -1501.3%.
The range of the Relative Valuation is (1,760.95) - (1,565.70) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 38.1x - 43.1x | 40.5x |
| Forward P/E multiples | 25.7x - 33.8x | 31.0x |
| Fair Price | (1,760.95) - (1,565.70) | (1,652.92) |
| Upside | -1592.8% - -1427.3% | -1501.3% |
| Date | P/E |
| 2024-09-06 | -2.55 |
| 2024-09-05 | -2.59 |
| 2024-09-04 | -2.62 |
| 2024-09-03 | -2.70 |
| 2024-08-30 | -2.89 |
| 2024-08-29 | -2.90 |
| 2024-08-28 | -2.93 |
| 2024-08-27 | -3.04 |
| 2024-08-26 | -2.98 |
| 2024-08-23 | -2.94 |
| 2024-08-22 | -2.79 |
| 2024-08-21 | -2.83 |
| 2024-08-20 | -2.77 |
| 2024-08-19 | -2.83 |
| 2024-08-16 | -2.80 |
| 2024-08-15 | -2.79 |
| 2024-08-14 | -2.66 |
| 2024-08-13 | -2.71 |
| 2024-08-12 | -2.53 |
| 2024-08-09 | -2.58 |
| 2024-08-08 | -2.77 |
| 2024-08-07 | -2.57 |
| 2024-08-06 | -2.44 |
| 2024-08-05 | -2.26 |
| 2024-08-02 | -2.31 |
| 2024-08-01 | -2.40 |
| 2024-07-31 | -2.48 |
| 2024-07-30 | -2.39 |
| 2024-07-29 | -2.34 |
| 2024-07-26 | -2.38 |
| 2024-07-25 | -2.34 |
| 2024-07-24 | -2.34 |
| 2024-07-23 | -2.45 |
| 2024-07-22 | -2.39 |
| 2024-07-19 | -2.34 |
| 2024-07-18 | -2.32 |
| 2024-07-17 | -2.43 |
| 2024-07-16 | -2.45 |
| 2024-07-15 | -2.22 |
| 2024-07-12 | -2.28 |
| 2024-07-11 | -2.27 |
| 2024-07-10 | -2.03 |
| 2024-07-09 | -2.01 |
| 2024-07-08 | -2.06 |
| 2024-07-05 | -1.98 |
| 2024-07-03 | -1.95 |
| 2024-07-02 | -1.90 |
| 2024-07-01 | -1.91 |
| 2024-06-28 | -1.88 |
| 2024-06-27 | -1.84 |